Profound Medical Corp <PRN.TO>: Losses of 46  cents announced for fourth quarter

7 March 2023 10:02 p.m. ​All figures in US dollars. The loss announced by Profound Medical Corp in the fourth quarter were lower than the Refinitiv mean estimate of losses. The company reported losses of -46 cents per share, 3 cents higher than the same quarter last year when the company reported EPS of -49 cents. Losses of -36 cents per share were anticipated by the five analysts providing estimates for the quarter. Wall Street expected results to range from -40 cents to -31 cents per share, with a forecasted mean of -36 cents per share. The company reported revenue of $1.26 million, which is lower than the estimated $2.72 million. RECOMMENDATIONS * The consensus recommendation for the company is "Buy". * The average consensus recommendation for the food retail & distribution peer group is also "Buy". FORECAST CHANGES * Three analysts are currently providing Refinitiv with estimates. * In the last week there have been no earnings estimate revisions by analysts covering the company. There was no change to the number of estimates. YEAR OVER YEAR * The company reported a fall in revenue to $1.26 million from $3.45 million in the same quarter last year.​ * Previous quarterly performance (using earnings preferred measure) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET, MISSED Oct. 31 2022 1.32​ 1.50 Beat Jul. 31 2022 1.62 1.77 Beat Apr. 30 2022 1.48 1.30 Missed​ Jan. 31 2022 1.50 1.53 Beat This summary was machine generated from Refinitiv data March 7 at 10:02 p.m.